Stock listing

Alector, Inc.

Selected listing: A2PCBM · LS · EUR · DE

Alector, Inc. (Lang & Schwarz: A2PCBM), Health Technology. Latest release Oct 5, 2026: Alector Enters Global License Agreement with Genentech for Brain…

A2PCBM:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2PCBM
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Alector, Inc.

Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases

October 5, 2026

Alector Reports Second Quarter 2026 Financial Results and Provides Business Update

August 6, 2026

Alector Reports First Quarter 2026 Financial Results and Provides Business Update

May 7, 2026

Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis

April 29, 2026

Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

February 25, 2026

All Alector, Inc. news →

Events

Replays

Alector, Inc. (ALEC) Q2 2025 Earnings Call
Thu, Aug 07, 2025 · 04:30 PM ET
Watch
Alector, Inc. (ALEC) Q4 2024 Earnings Call
Wed, Feb 26, 2025 · 04:30 PM ET
Watch
Alector, Inc. (ALEC) Q2 2024 Earnings Call
Wed, Aug 07, 2024 · 04:30 PM ET
Watch

Research Alector, Inc.

Alector, Inc. company profile

View the public company page for Alector, Inc. on 6ix.

Alector, Inc. news

Read company news and market updates connected to Alector, Inc..

Alector, Inc. investor events

Find investor webinars, events, and replay context for Alector, Inc..